Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer’s disease by Charou, D, Rogdakis, T, Latorrata, A, Valcarcel, M, Papadogiannis, V, Athanasiou, C, Tsengenes, A, Papadopoulou, MA, Lypitkas, D, Lavigne, MD, Katsila, T, Wade, RC, Cader, MZ, Calogeropoulou, T, Gravanis, A, Charalampopoulos, I

Structure-kinetic relationship reveals the mechanism of selectivity of FAK inhibitors over PYK2 by Berger, B-T, Amaral, M, Kokh, DB, Nunes-Alves, A, Musil, D, Heinrich, T, Schröder, M, Neil, R, Wang, J, Navratilova, I, Bomke, J, Elkins, JM, Müller, S, Frech, M, Wade, RC, Knapp, S